CD34 and hepatocellular carcinoma: Since the HCC tumor interacts with both infiltrating immune cells and liver-resident cells, orthotopic implantation of a PDX in the hepatic micro-environment of CD34+-humanized mice would represent an even more attractive platform for preclinical evaluation of immunotherapeutic and other HCC treatment strategies but remains to be developed.